Humacyte Inc (NAS:HUMA)
$ 0.71 -0.0063 (-0.9%) Market Cap: 190.80 Mil Enterprise Value: 208.16 Mil PE Ratio: 0 PB Ratio: 13.61 GF Score: 23/100

Humacyte Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2026 / 05:00PM GMT
Release Date Price: $1.24 (+3.33%)
Matthew Miksic
Barclays Services Corp - Analyst

All right. Well, we are a couple of minutes into our time here. So we're going to have to talk fast, Laura.

Laura Niklason
Humacyte Inc - President, Chief Executive Officer, Director

Okay.

Matthew Miksic
Barclays Services Corp - Analyst

I am very pleased to have with us here at our conference Humacyte. Laura Niklason, Dr. Laura Niklason, Founder, President and Chief Executive Officer; and Dale Sander, CFO. So thank you for coming.

Questions & Answers

Matthew Miksic
Barclays Services Corp - Analyst

Just a quick snippet of history. I've told you before, I think we've met a long time ago in very early stages and I was fascinated by the technology and a lot of things happened from that meeting to like launching in the last year or two. I feel like I've missed the hard part and showed up for the good part, the fun part, maybe. So but it's been fun to see this develop over the years. So with that sort of prelude,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot